Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid.
Anzano
M A
MA
Laboratory of Chemoprevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Peer
C W
CW
Smith
J M
JM
Mullen
L T
LT
Shrader
M W
MW
Logsdon
D L
DL
Driver
C L
CL
Brown
C C
CC
Roberts
A B
AB
Sporn
M B
MB
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000008:administration & dosage; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control*; D010880:Piperidines / Q000008:administration & dosage; D020849:Raloxifene Hydrochloride; D051381:Rats; D017207:Rats, Sprague-Dawley; D014212:Tretinoin / Q000008:administration & dosage
D004965:Estrogen Antagonists; D010880:Piperidines; D020849:Raloxifene Hydrochloride; D014212:Tretinoin